ライフサイエンスコーパス: female breast cancer

1 ranging from 31% for any leukemia to 89% for female breast cancer.

2 e breast cancer resembled that of late-onset female breast cancer.

3 y, male breast cancer is often compared with female breast cancer.

4 s for radiotherapy, by stage, are similar to female breast cancer.

5 r information for comparison with studies of female breast cancer.

6 predisposition to ovarian cancer as well as female breast cancer.

7 of which had a family history of male and/or female breast cancer.

8 ng cancer, and 0.88 (95% CI: 0.56, 1.39) for female breast cancer.

9 y of cancer are established risk factors for female breast cancer.

10 stases in an immune-competent mouse model of female breast cancer.

11 es in excess relative and absolute risk from female breast cancer.

12 cess relative and absolute risks of male and female breast cancers.

13 etiology of male breast cancers, similar to female breast cancers.

14 cancers, female breast cancer, and bilateral female breast cancers.

15 lele from XCI offers a potential therapy for female breast cancers.

16 esearch tool and a potential therapeutic for female breast cancers.

17 tion of FOXP3 in various cell lines of human female breast cancers.

18 CHEK2 had three times the population risk of female breast cancer (145 cases: SIR 3.48 (95% CI 2.96-4

19 e 80 years were 53% (95% CI, 44% to 63%) for female breast cancer, 5% (95% CI, 2% to 10%) for ovarian

20 n-associated relative risk for male than for female breast cancer, although absolute excess risks for

21 ds in the age-adjusted incidence of invasive female breast cancer and compared these with trends in t

22 rphism was associated with increased risk of female breast cancer and may modify the relation between

23 ed for any cancer, multiple primary cancers, female breast cancer, and bilateral female breast cancer

24 nown associations of ionizing radiation with female breast cancer, and emerging evidence also for mal

25 s showed a >100-fold higher risk of sarcoma, female breast cancer, and hematologic malignancies for t

26 nts (ozone and PM(2.5)) and prostate cancer, female breast cancer, and melanoma of the skin across mu

27 of families with multiple case, early onset female breast cancer, and they are also associated with

28 late effect of concern, using second-primary female breast cancer as an example.

29 me [PHTS]) confer up to 85% lifetime risk of female breast cancer (BC).

30 Female breast cancer (BrCa) is the most common noncutane

31 ed significantly over time for both male and female breast cancer, but progress for men has lagged be

32 ome-wide association study data from 172,737 female breast cancer cases and 242,009 controls of Afric

33 quencing data of BRCA1 and BRCA2 from 96,691 female breast cancer cases and 302,116 controls from thr

34 ge-matched case-control study identified 735 female breast cancer cases and 735 female controls witho

35 s analyzed data from a case-control study of female breast cancer conducted in Connecticut in 1994-19

36 al benefit was concentrated in patients with female breast cancer (DD, 1.20 ppt; 95%CI, 0.27 to 2.12)

37 notypically, there is evidence that male and female breast cancer differ in their molecular landscape

38 gram collected 600,000+ in situ and invasive female breast cancers during the years 1950 to 2003.

39 s from tumor tissues of six MBC and thirteen female breast cancer (FBC) patients.

40 In the United Kingdom, female breast cancer following occupational radiation ex

41 iver, stomach, kidney, lung, colorectal, and female breast cancers had higher incidence rates among A

42 Improved outcomes in HER2+ female breast cancer have resulted from chemotherapy and

43 on with family cancer history on the risk of female breast cancer in Shanghai, China.

44 ecrease in the overall incidence of invasive female breast cancer in the United States was reported.

45 D exposure domains for colorectal, lung, and female breast cancer incidence cumulatively over time us

46 Bias in age-adjusted trends in female breast cancer incidence is shown graphically befo

47 Risk in patients with BBD compared with female breast cancer incidence rates from the Iowa Surve

48 ely, of relative risk for male compared with female breast cancer incidence, the former borderline si

49 Female breast cancer is the most commonly diagnosed canc

50 interaction activates an ACC->BLA circuit in female breast cancer model mice, reducing anxiety, norep

51 rs conducted a retrospective analysis of (a) female breast cancer mortality rates from NCHS data for

52 Conclusion Female breast cancer mortality rates have stopped declin

53 the investigation of birth cohort trends in female breast cancer mortality rates obtained from the N

54 .3 million new cases and 670,000 deaths from female breast cancer occurred in 2022.

55 Male compared with female breast cancers occurred later in life with higher

56 , 95% confidence interval (CI) = 1.29-1.46), female breast cancer (OR = 1.42, 95% CI = 1.27-1.58), th

57 anic White patients with male breast cancer, female breast cancer, or ovarian cancer who underwent te

58 ated the current and future global burden of female breast cancer overall, and by age group, in 185 c

59 focus group feedback, was administered to 95 female breast cancer participants twice within 1 to 2 we

60 s were established from blood samples of 100 female breast cancer patients and 105 healthy controls.

61 spanic, African American, and Asian American female breast cancer patients compared with non-Hispanic

62 ial (mtSNPs) and nuclear (nuSNPs) genomes of female breast cancer patients in The Cancer Genome Atlas

63 28F heterozygotes were 2.88% (47/1632) among female breast cancer patients not selected for family hi

64 t diagnosis was investigated in over 106,000 female breast cancer patients reported during 1992-1996

65 and Kaplan-Meier plot suggest that the TCGA female breast cancer patients with low gene expression o

66 in a population-based, multiethnic series of female breast cancer patients younger than 65 years at d

67 uclear cells of healthy donors or metastatic female breast cancer patients, induce robust, sustained

68 Newly diagnosed, ER/PR+, stage 0-III, female breast cancer patients, were recruited.

69 Mutations were detected in both male and female breast cancer patients.

70 nd leukemia for both sexes; corpus uteri and female breast cancer; prostate cancer), for three age gr

71 demiologic findings on cigarette smoking and female breast cancer risk may reflect insufficient asses

72 ociated with an increased rate of subsequent female breast cancer (RR, 3.7; 95% CI, 1.8 to 7.7), espe

73 d associations between PALB2 PVs and risk of female breast cancer (RR, 7.18; 95% CI, 5.82 to 8.85; P

74 The rate of female breast cancer showed evidence of recovery to prev

75 Of the 4 screening-detected cancers, only female breast cancer showed significant recovery in 2021

76 9.51; 95% CI, 1.15 to 34.37; P = .009), and female breast cancer (SIR, 3.95; 95% CI, 1.59 to 8.13; P

77 Eligibility criteria in both cohorts were female breast cancer survivors (stage I-III) aged 20-84

78 One hundred twenty-three healthy female breast cancer survivors and 87 women without canc

79 ucted a prospective cohort analysis in 3,223 female breast cancer survivors from five racial/ethnic p

80 ticles describing exercise communication for female breast cancer survivors in any geographical locat

81 large, population-based cohort study of 5042 female breast cancer survivors in China.

82 Sixty female breast cancer survivors with hot flashes were ran

83 A self-report measure of body image in female breast cancer survivors, the Body Image and Relat

84 and reproductive health outcomes in younger female breast cancer survivors.

85 in the home, is associated with the risk of female breast cancer, the authors analyzed data from a p

86 Risks of total solid and female breast cancer, the most common cancer type, were

87 kemia, testicular cancer, ovarian cancer, or female breast cancer treated with chemotherapy.

88 vestigated in a nested case-control study of female breast cancer within a cohort of African American